Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun 30;58(53):7384-7387.
doi: 10.1039/d2cc02278h.

Albumin-mediated extracellular zinc speciation drives cellular zinc uptake

Affiliations

Albumin-mediated extracellular zinc speciation drives cellular zinc uptake

James P C Coverdale et al. Chem Commun (Camb). .

Abstract

The role of the extracellular medium in influencing metal uptake into cells has not been described quantitatively. In a chemically-defined model system containing albumin, zinc influx into endothelial cells correlates with the extracellular free zinc concentration. Allosteric inhibition of zinc-binding to albumin by free fatty acids increased zinc flux.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts to declare.

Figures

Fig. 1
Fig. 1. Serum albumin is the principal Zn2+ transporter in the extracellular space. Amino acid residues His67, His247 and Asp249 form site A (blue; PDB 5IJF; HSA), the principlal interdomain binding site for Zn2+ (red sphere). In the presence of FFAs of sufficient chain length bound at the nearby FFA binding site FA2 (myristate C14:0 shown in black), site A residues disengage, as depicted in the structural overlay (centre), and Zn2+ affinity drops dramatically, leading to release of Zn2+ from FFA-loaded albumin (tan; PDB 1BJ5; HSA) under physiological conditions.
Fig. 2
Fig. 2. 66Zn/68Zn ratios determined at different extracellular albumin concentrations (0–600 μM; see ESI for full data). Phase I: HUVEC growth medium. Phase II: Physiologically-relevant media (600 μM BSA + 20 μM natural abundance Zn2+, no FFA). Phase III: Media containing variable concentration of BSA (0-600 μM) + 20 μM isotopically-enriched 68Zn2+, with/without FFA supplementation. Cell pellets were collected in a time-dependent manner and analysed by ICP-MS. (a) 66Zn/68Zn ratios were calculated, plotted and fitted to a mathematical model to derive zinc flux rates. Zinc flux increases with decreasing BSA concentration. (b) Zinc isotopes (64Zn, 66Zn, 67Zn, 68Zn, 70Zn) were summed up to determine total intracellular zinc (ng × 106 cells). For extracellular [BSA] > 60 μM, intracellular [Zn] remained constant at ca. 50 ng × 106 cells but increased for extracellular [BSA] < 40 μM. See ESI, Tables S2–S5 and S9–S13 for full numerical data and mathematical models.
Fig. 3
Fig. 3. Zinc influx depends on the concentration of albumin (a). This can be correlated to free [Zn2+] for [BSA] = 40–600 μM (estimated using published stability constants for site A only; see ESI†) (b). The influx rate shows a linear relationship with free [Zn2+].
Fig. 4
Fig. 4. Isotopic ratios (66Zn/68Zn) over time for HUVEC cells cultured in presence of 60 μM BSA and either C8:0 (octanoate), C14:0 (myristate) or C16:0 (palmitate) FFAs (300 μM, 5 mol. equiv.). Experimental data (•) are shown with corresponding fitting model for that experimental condition (solid coloured line) alongside the fitting model for 60 μM BSA in the absence of FFAs (dashed black line). The right-hand panel compares the influx rates φin for these four conditions. Full numerical data can be found in ESI, Tables S6, S7 and S14–S16.

Similar articles

Cited by

References

    1. Krezel A. Maret W. J. Biol. Inorg. Chem. 2006;11:1049–1062. doi: 10.1007/s00775-006-0150-5. - DOI - PubMed
    1. King J. C. Am. J. Clin. Nutr. 2011;94:679s–684s. doi: 10.3945/ajcn.110.005744. - DOI - PMC - PubMed
    1. Rükgauer M. Klein J. Kruse-Jarres J. D. J. Trace Elem. Med. Biol. 1997;11:92–98. doi: 10.1016/S0946-672X(97)80032-6. - DOI - PubMed
    1. Foster A. W. Osman D. Robinson N. J. J. Biol. Chem. 2014;289:28095–28103. doi: 10.1074/jbc.R114.588145. - DOI - PMC - PubMed
    1. Foote J. W. Delves H. T. Analyst. 1988;109:709–711. doi: 10.1039/AN9840900709. - DOI - PubMed